These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 14582078)
21. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias. Han X; Bueso-Ramos CE Am J Clin Pathol; 2007 Apr; 127(4):528-44. PubMed ID: 17369128 [TBL] [Abstract][Full Text] [Related]
22. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273 [TBL] [Abstract][Full Text] [Related]
23. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871 [TBL] [Abstract][Full Text] [Related]
24. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Van Vlierberghe P; van Grotel M; Beverloo HB; Lee C; Helgason T; Buijs-Gladdines J; Passier M; van Wering ER; Veerman AJ; Kamps WA; Meijerink JP; Pieters R Blood; 2006 Nov; 108(10):3520-9. PubMed ID: 16873670 [TBL] [Abstract][Full Text] [Related]
26. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy. Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520 [TBL] [Abstract][Full Text] [Related]
27. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia. Grutz G; Forster A; Rabbitts TH Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886 [TBL] [Abstract][Full Text] [Related]
29. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600 [TBL] [Abstract][Full Text] [Related]
30. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia. François S; Delabesse E; Baranger L; Dautel M; Foussard C; Boasson M; Blanchet O; Bernard O; Macintyre EA; Ifrah N Genes Chromosomes Cancer; 1998 Sep; 23(1):36-43. PubMed ID: 9713995 [TBL] [Abstract][Full Text] [Related]
31. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene. Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574 [TBL] [Abstract][Full Text] [Related]
32. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1. Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838 [TBL] [Abstract][Full Text] [Related]
35. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836 [TBL] [Abstract][Full Text] [Related]
36. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769 [TBL] [Abstract][Full Text] [Related]
37. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Hatano M; Roberts CW; Minden M; Crist WM; Korsmeyer SJ Science; 1991 Jul; 253(5015):79-82. PubMed ID: 1676542 [TBL] [Abstract][Full Text] [Related]
39. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis. Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685 [TBL] [Abstract][Full Text] [Related]
40. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Baer R Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]